NCT00002223已完成不适用
Ritonavir (ABT-538)/Indinavir Combination Treatment in HIV-Infected Patients Previously Receiving Indinavir 800 mg TID
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Abbott
- 试验地点
- 11
研究概览
简要总结
The purpose of this study is to determine how many HIV-infected patients continue taking ritonavir/indinavir combination after having taken indinavir three times a day as part of their anti-HIV drug therapy. This study also examines the safety and effectiveness of the ritonavir/indinavir combination.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (11)
Loading locations...
相似试验
已完成
不适用
Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) RegimensHIV InfectionsNCT02191319Boehringer Ingelheim55
已完成
不适用
Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®HIV InfectionsNCT02191293Boehringer Ingelheim228
已完成
不适用
Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy RegimenHIV InfectionsNCT02191332Boehringer Ingelheim147
已完成
1 期
The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy VolunteersHIVFenofibrateProtease InhibitorsGlucuronosyltransferaseHypertriglyceridemiaNCT01148004National Institutes of Health Clinical Center (CC)25
Enrolling By Invitation
不适用
Analysis of HIV-1 Replication During Antiretroviral TherapyHIVNCT00767312National Institute of Allergy and Infectious Diseases (NIAID)70